跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
达纳康 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ginkgo Biloba Leaves Extract Tablets
Approved
化学药品
Ginkgo Biloba Leaves Extract Tablets
IPSEN CONSUMER HEALTHCARE
🇨🇳 National Medical Products Administration
Approval Date
Feb 28, 2024
Approval ID
8ZY507Eorgx
Company
IPSEN CONSUMER HEALTHCARE
Type
化学药品
Approval Details
Approval Id
8ZY507Eorgx
Approval Number
国药准字HJ20160031
Generic Name
银杏叶片
Generic Name En
Ginkgo Biloba Leaves Extract Tablets
Trade Name
达纳康
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含银杏叶提取物40mg(总黄酮醇苷9.8mg,萜类内酯2.4mg)
Reg Date
2024-02-28
Expired Date
2029-02-27
Company Name
IPSEN CONSUMER HEALTHCARE
Production Company Name
BEAUFOUR IPSEN INDUSTRIE
Company Detail Path
/organization/ipsen-consumer-healthcare
Production Company Detail Path
/organization/beaufour-ipsen-industrie
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 28, 2024
Approval ID
8ZY507Eorgx
Type
化学药品
Back to NMPA Approvals